The proteomic data revealed that Eμ-Myc/cRel−/− lymphoma cells had substantially rewired their cell signalling pathways, with a high level of both down (589) and up-regulated (517) phosphopeptides compared with wild-type (Figure 2C, Supplementary Figure S3A). The gene discussed is MYC; the disease is lymphoma.